Shang-Gin Wu

9PUBLICATIONS
29CO-AUTHORS
Gene and molecular therapyMolecular targetsCancer diagnosisLiquid biopsiesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 20, 2026
Mechanisms of Acquired Resistance Following Dual EGFR/MET Inhibition in MET-Amplified EGFR TKI-Resistant Lung Cancer.

|Dec 23, 2024
Atezolizumab, bevacizumab, pemetrexed and platinum for EGFR-mutant NSCLC patients after EGFR TKI failure: A phase II study with immune cell profile analysis.

Shang-Gin Wu, Chao-Chi Ho, James Chih-Hsin Yang

|Nov 21, 2024
Multiomics Analysis Reveals Molecular Changes during Early Progression of Precancerous Lesions to Lung Adenocarcinoma in Never-Smokers.

Yun-Ching Chen, Chia-Lang Hsu, Hui-Min Wang

|Dec 23, 2023
Tissue or liquid rebiopsy? A prospective study for simultaneous tissue and liquid NGS after first-line EGFR inhibitor resistance in lung cancer.

Yen-Ting Lin, Chao-Chi Ho, Wei-Hsun Hsu

|May 22, 2023
MiR-503 pleiotropically regulates epithelial-mesenchymal transition and targets PTK7 to control lung cancer metastasis.

Tzu-Hsiu Tsai, Chien-Hung Gow, Yi-Nan Liu

|Mar 13, 2023
Different treatment efficacies and T790M acquisition of EGFR-TKIs on NSCLC patients with variable Del-19 subtypes of EGFR.

Shang-Gin Wu, Chien-Hung Gow, Yi-Ling Chen

Pageof 2

Frequent Collaborators

5 joint publications

Jin-Yuan Shih

3 joint publications

Yen-Ting Lin

2 joint publications

Chao-Chi Ho

2 joint publications

Chien-Hung Gow